Profil

Lambert Frédéric

Département des sciences biomédicales et précliniques

See author's contact details
Main Referenced Co-authors
Koopmansch, Benjamin  (11)
Bours, Vincent  (9)
El Housni, H. (4)
Herens, Christian  (4)
Beguin, Yves  (3)
Main Referenced Keywords
Humans (7); Middle Aged (3); Adult (2); Aged (2); Gene Expression Regulation, Neoplastic (2);
Main Referenced Unit & Research Centers
GIGA‐R - Giga‐Research - ULiège [BE] (1)
Giga-Cancer - ULiège [BE] (1)
Giga-Signal Transduction - ULiège [BE] (1)
Giga-Signal Transduction, GIGA-R (1)
Main Referenced Disciplines
Hematology (15)
Genetics & genetic processes (13)
Oncology (7)
Biochemistry, biophysics & molecular biology (3)
Laboratory medicine & medical technology (2)

Publications (total 38)

The most downloaded
1471 downloads
JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276. https://hdl.handle.net/2268/184321

The most cited

217 citations (Scopus®)

Lahortiga, I., De Keersmaecker, K., Van Vlierberghe, P., Graux, C., Cauwelier, B., Lambert, F., Mentens, N., Beverloo, H. B., Pieters, R., Speleman, F., Odero, M. D., Bauters, M., Froyen, G., Marynen, P., Vandenberghe, P., Wlodarska, I., Meijerink, J. P. P., & Cools, J. (May 2007). Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nature Genetics, 39 (5), 593-595. doi:10.1038/ng2025 https://hdl.handle.net/2268/14458

Pirotte, M., De Voeght, A., VERTENOEIL, G., Vasbien Myriam, Paridaens, H., Somja, J., Collins, P., & Lambert, F. (December 2023). VACUOLES, E1 ENZYME, X-LINKED, AUTOINFLAMMATORY, SOMATIC SYNDROME (VEXAS SYNDROME) WITH MULTIPLE THROMBOEMBOLISM EVENTS: A BELGIAN CASE REPORT. Belgian Journal of Hematology, 14 (8), 336–42.
Peer Reviewed verified by ORBi

Crake, R., Gasmi, I., Dehaye, J., Lardinois, F., Peiffer, R., Maloujahmoum, N., Agirman, F., KOOPMANSCH, B., D’Haene, N., Azurmendi Senar, O., Arsenijevic, T., Lambert, F., Peulen, O., Van Laethem, J.-L., & Bellahcene, A. (17 May 2023). Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Cells, 12 (10), 1414. doi:10.3390/cells12101414
Peer Reviewed verified by ORBi

LETE, C., FERNANDEZ CARAZO, R., MENTEN, C., BECKERS, P., KOOPMANSCH, B., FRANKE, S., DE PRIJCK, B., JAMAR, M., LAMBERT, F., & BOURS, V. (July 2021). A case of early-T-cell precursor acute lymphoblastic leukemia with e6a2 BCR-ABL1 fusion transcript [Poster presentation]. 13th European Cytogenomics Conference.

Trimech, M., Letourneau, A., Missiaglia, E., DE PRIJCK, B., Nagy-Hulliger, M., SOMJA, J., Vivario, M., Gaulard, P., LAMBERT, F., Bisig, B., & de Leval, L. (2021). Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome. American Journal of Surgical Pathology, 45, 773-786. doi:10.1097/PAS.0000000000001646
Peer Reviewed verified by ORBi

DOCAMPO MARTINEZ, E., MARTIN, M., GANGOLF, M., HARVENGT, J., BULK, S., SEGERS, K., LEROI, N., LETE, C., PALMARICCIOTTI, V., Freire Chadrina, M., LAMBERT, F., & Bours, V. (2021). Hérédité et cancer. Revue Médicale de Liège, 76 (5-6), 327-336.
Peer reviewed

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012
Peer Reviewed verified by ORBi

FERNANDEZ CARAZO, R., KOOPMANSCH, B., PALMEIRA, L., CHARLOTEAUX, B., & LAMBERT, F. (2020). Hematopoietic Malignancies with Germline Predisposition Diagnosis with Filtered Whole Exome Sequencing and in silico Panel Analysis [Poster presentation]. European School of Haematology 2020.

LOVINFOSSE, P., POLUS, M., VAN DAELE, D., Martinive, P., DAENEN, F., Hatt, M., Visvikis, D., KOOPMANSCH, B., LAMBERT, F., COIMBRA MARQUES, C., SEIDEL, L., Albert, A., Delvenne, P., & Hustinx, R. (2018). FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-017-3855-5
Peer Reviewed verified by ORBi

Herfs, M., RONCARATI, P., KOOPMANSCH, B., Peulen, O., Bruyère, D., Lebeau, A., Hendrick, E., Hubert, P., PONCIN, A., Penny, W., Piazzon, N., Monnien, F., Guenat, D., Mougin, C., Prétet, J.-L., Vuitton, L., SEGERS, K., LAMBERT, F., BOURS, V., ... Delvenne, P. (2018). A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalized medicine. British Journal of Cancer, 118(10), 1302-1312. doi:10.1038/s41416-018-0049-2
Peer Reviewed verified by ORBi

Delefortrie, Q., LAMBERT, F., Bulliard, G., Jurdan, M., Toffoli, S., Sartenaer, D., Theate, I., de Prophetis, S., Pranger, D., Konreich, A., & Mineur, P. (2017). A 54-year-old woman with a myeloid neoplasm associated with eosinophilia and t(5;12)(q33;p13)/PDFRFB rearrangement : case report and mini-review of the literature. Clinical Medical Reviews and Case Reports. doi:10.23937/2378-3656/1410170
Peer Reviewed verified by ORBi

SAGOT, C., CHARLIER, H., KOOPMANSCH, B., & LAMBERT, F. (29 January 2016). Two cases of atypical CALR mutations in MPN patients [Poster presentation]. BHS General annual meeting 2016.

KOOPMANSCH, B., LOPEZ Y CADENAS, M., Hennuy, B., & LAMBERT, F. (29 January 2016). Identification of a TPM3-PDGFRB fusion transcript and its chromosomal breakpoints by RNA-Seq in a case of Chronic Eosinophilic Leukemia [Poster presentation]. BHS General Annual Meeting 2016, United States - Texas.

LOVINFOSSE, P., KOOPMANSCH, B., LAMBERT, F., JODOGNE, S., KUSTERMANS, G., Hatt, M., Visvikis, D., SEIDEL, L., POLUS, M., Albert, A., DELVENNE, P., & HUSTINX, R. (2016). 18F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. British Journal of Radiology, 20160212. doi:10.1259/bjr.20160212
Peer Reviewed verified by ORBi

Maes, B., Bakkus, M., Boeckx, N., Boone, E., Cauwelier, B., Denys, B., De Schouwer, P., Devos, T., El Housni, H., Hillen, F., Jacobs, K., LAMBERT, F., Louagie, H., Maes, M.-B., Meeus, P., Moreau, E., Nollet, F., Peeters, K., Saussoy, P., ... Bruyndonckx, R. (2016). A novel approach for BCR-ABL1 standardization to improve International Scale estimation. International Journal of Laboratory Hematology, 38 (6), 674-684. doi:10.1111/ijlh.12556
Peer Reviewed verified by ORBi

Roufosse, F., Heimann, P., LAMBERT, F., Sidon, P., Bron, D., Cottin, V., & Cordier, J.-F. (2016). Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association. Respiration: International Review of Thoracic Diseases. doi:10.1159/000446076
Peer Reviewed verified by ORBi

JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276.
Peer reviewed

DIDEBERG, V., SEGERS, K., KOOPMANSCH, B., LAMBERT, F., & Bours, V. (2015). PHARMACOGENOMIQUE ET MEDECINE PERSONNALISEE : VERS UN SCREENING SYSTEMATIQUE DE LA POPULATION ? Revue Médicale de Liège, 70 (5-6), 251-6.

FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., Bonnet, C., BEGUIN, Y., JAMAR, M., LAMBERT, F., & GOTHOT, A. (2015). Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

CAERS, J., HAFRAOUI, K., KEUTGENS, A., CABERG, J.-H., LAMBERT, F., TASSIN, F., & BEGUIN, Y. (02 February 2014). Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide. European Journal of Haematology, 92 (2), 179-180. doi:10.1111/ejh.12233
Peer Reviewed verified by ORBi

Bento, C., Percy, M. J., Gardie, B., Maia, T. M., van Wijk, R., Perrotta, S., Della Ragione, F., Almeida, H., Rossi, C., Girodon, F., Astrom, M., Neumann, D., Schnittger, S., Landin, B., Minkov, M., Randi, M. L., Richard, S., Casadevall, N., Vainchenker, W., ... Ugo, V. (2014). Genetic basis of congenital erythrocytosis: mutation update and online databases. Human Mutation, 35 (1), 15-26. doi:10.1002/humu.22448
Peer Reviewed verified by ORBi

Bonnet, C., MENTEN, C., LAMBERT, F., Gothot, A., Baron, F., CAERS, J., HERENS, C., & Beguin, Y. (25 January 2013). Simultaneous diagnosis of CLL and CML in a single patient with evidence for two different cell clones [Poster presentation]. BHS, General Annual Meeting.

Rozen, L., Huybrechts, S., Dedeken, L., Heijmans, C., Dessars, B., Heimann, P., LAMBERT, F., Noubouossie, D. F., Ferster, A., & Demulder, A. (2013). Transient leukemia in a newborn without Down syndrome: case report and review of the literature. European Journal of Pediatrics. doi:10.1007/s00431-013-2163-8
Peer Reviewed verified by ORBi

Duhoux, F. P., Ameye, G., Lambot, V., HERENS, C., LAMBERT, F., Raynaud, S., Wlodarska, I., Michaux, L., Roche-Lestienne, C., Labis, E., Taviaux, S., Chapiro, E., Khac, F. N., Struski, S., Dobbelstein, S., Dastugue, N., Lippert, E., Speleman, F., Van Roy, N., ... Poirel, H. A. (2011). Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies. PLoS ONE, 6 (10), 26311. doi:10.1371/journal.pone.0026311
Peer Reviewed verified by ORBi

De Weer, A., Van der Meulen, J., Rondou, P., Taghon, T., Konrad, T. A., De Preter, K., Mestdagh, P., Van Maerken, T., Van Roy, N., Jeison, M., Yaniv, I., Cauwelier, B., Noens, L., Poirel, H.-A., Vandenberghe, P., LAMBERT, F., De Paepe, A., Sanchez Mainar, M., Odero, M., ... Speleman, F. (2011). EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells. British Journal of Haematology, 154 (3), 337-48. doi:10.1111/j.1365-2141.2011.08737.x
Peer Reviewed verified by ORBi

Robert, I., Aussems, M., Keutgens, A., Zhang-Shao, X., Hennuy, B., Viatour, P., Vanstraelen, G., Merville, M.-P., Chapelle, J.-P., de Leval, L., LAMBERT, F., Dejardin, E., Gothot, A., & Chariot, A. (02 April 2009). Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-κB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. Oncogene, 28 (13), 1626-1638. doi:10.1038/onc.2009.6
Peer Reviewed verified by ORBi

Nollet, F., Bakkus, M., Meeus, P., Demanet, C., Schaaf-Lafontaine, N., FRANKE, S., Chatelain, B., Vermeulen, K., Boone, E., El Housni, H., Heimann, P., Husson, B., LAMBERT, F., Vannuffel, P., Saussoy, P., Maes, B., & Deschouwer, P. (2009). Guidelines for an integrated diagnostic approach of chronic lymphoproliferative disorders in the routine laboratory of haematology in Belgium. Acta Clinica Belgica, 64 (6), 494-504. doi:10.1179/acb.2009.085
Peer Reviewed verified by ORBi

Herens, C., Lambert, F., Quintanilla-Martinez, L., Bisig, B., Deusings, C., & De Leval, L. (2008). Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression. Blood, 111 (3), 1745-6. doi:10.1182/blood-2007-10-120824
Peer Reviewed verified by ORBi

Lambert, F., Heimann, P., Herens, C., Chariot, A., & Bours, V. (July 2007). Consultations in molecular diagnostics - A case of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia with a rare FIP1L1 breakpoint. Journal of Molecular Diagnostics, 9 (3), 414-419. doi:10.2353/jmoldx.2007.060196
Peer Reviewed verified by ORBi

Lahortiga, I., De Keersmaecker, K., Van Vlierberghe, P., Graux, C., Cauwelier, B., Lambert, F., Mentens, N., Beverloo, H. B., Pieters, R., Speleman, F., Odero, M. D., Bauters, M., Froyen, G., Marynen, P., Vandenberghe, P., Wlodarska, I., Meijerink, J. P. P., & Cools, J. (June 2007). Duplication of the MYB oncogene in T-cell acute lymphoblastic leukemia. Haematologica, 92 (Suppl. 1), 164.
Peer Reviewed verified by ORBi

Lahortiga, I., De Keersmaecker, K., Van Vlierberghe, P., Graux, C., Cauwelier, B., Lambert, F., Mentens, N., Beverloo, H. B., Pieters, R., Speleman, F., Odero, M. D., Bauters, M., Froyen, G., Marynen, P., Vandenberghe, P., Wlodarska, I., Meijerink, J. P. P., & Cools, J. (May 2007). Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nature Genetics, 39 (5), 593-595. doi:10.1038/ng2025
Peer Reviewed verified by ORBi

Robe, P., Nguyen-Khac, M.-T., Lambert, F., Lechanteur, C., Jolois, O., Ernst-Gengoux, P., Rogister, B., & Bours, V. (January 2007). Sufasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. International Journal of Oncology, 30 (1), 283-290. doi:10.3892/ijo.30.1.283
Peer Reviewed verified by ORBi

Lahortiga, I., Graux, C., Mentens, N., Van Roosbroeck, K., De Keersmaecker, K., Lambert, F., Vandenberghe, P., Wlodarska, I., Froyen, G., Odero, M. D., Marynen, P., & Cools, J. (16 November 2006). Array-CGH analysis of T-ALL patients and cell lines. Blood, 108 (11, Part 2), 195B-196.
Peer Reviewed verified by ORBi

Sidon, P., Heimann, P., Lambert, F., Dessars, B., Robin, V., & El Housni, H. (July 2006). Combined locked nucleic acid and molecular beacon technologies for sensitive detection of the JAK2(V617F) somatic single-base sequence variant. Clinical Chemistry, 52 (7), 1436-1438. doi:10.1373/clinchem.2006.066886
Peer Reviewed verified by ORBi

Dessars, B., El Housni, H., Lambert, F., Kentos, A., & Heimann, P. (May 2006). Rational use of the EAC real-time quantitative PCR protocol in chronic myelogenous leukemia: report of three false-negative cases at diagnosis. Leukemia, 20 (5), 886-888. doi:10.1038/sj.leu.2404174
Peer Reviewed verified by ORBi

Lambert, F., Schioppa, A., Castermans, S., Lopez, M.-J., Chariot, A., & Bours, V. (2006). Accurate genotyping of the V617F janus kinase (JAK) 2 mutation combining ARMS PCR and capillary electrophoresis. Acta Clinica Belgica, 61 (2, MAR-APR), 108.
Peer Reviewed verified by ORBi

Jacquy, C., Soree, A., Lambert, F., Bosly, A., Ferrant, A., Andre, M.-E., Parma, J., Kentos, A., & Martiat, P. (2000). A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells. British Journal of Haematology, 110 (3), 631-7. doi:10.1046/j.1365-2141.2000.02244.x
Peer Reviewed verified by ORBi

Jacquy, C., Lambert, F., Soree, A., Van Daele, S., Heusterspreute, M., Bosly, A., Ferrant, A., Parma, J., Bron, D., & Martiat, P. (1999). Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging? Bone Marrow Transplantation, 23 (7), 681-6. doi:10.1038/sj.bmt.1701637
Peer Reviewed verified by ORBi

Leclercq, D., Boxus, E., De Brogniez, P., Wuidar, H., & Lambert, F. (1993). The taste approach : general implicit solutions in MCQs, confidence marking, open books exams and interactive testing. In D. Leclercq, Item banking, self-assessment and interactive testing : actes du NATO ARW Conférence de Liège, novembre 1992. Heidelberg, Germany: Springer Verlag.
Peer reviewed

Contact ORBi